Description:
TRANSLOCATED CHROMOSOME
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Chromosome Abnormalities |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
2
|
Relation to Proband
|
father
|
Confirmation
|
Karyotypic analysis after cell line submission to CCR
|
ISCN
|
46,XY,t(10;17)(10pter>10q24::17p13> 17pter;17qter>17p13::10q24>10qter)
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
4 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
|
Cytogenetics |
Chromosome 10: TRANSLOCATION Breakpoint 10q24 t(10;17)10q24 |
|
Chromosome 17: TRANSLOCATION Breakpoint 17p13 t(10;17)17p13 |
Remarks |
Clinically normal; balanced carrier; son with the unbalanced translocation is not in the Repository; a relative with the same unbalanced translocation is GM00959 |
Spritz RA, Emanuel BS, Chern CJ, Mellman WJ, Gene dosage effect: intraband mapping of human soluble glutamic oxaloacetic transaminase. Cytogenet Cell Genet23:149-56 1979 |
PubMed ID: 436447 |
|
Zackai E, Mellman W, Aronson M, Miller RC, Greene AE, Coriell LL, A (10;17) translocation, balanced, 46 chromosomes. Repository identification No. GM-216. Cytogenet Cell Genet14:88-9 1975 |
PubMed ID: 1132254 |
Passage Frozen |
4 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|